Optimized large-scale production of high titer lentivirus vector pseudotypes

Journal of Virological Methods

Volumn 122, Issue 2, 2004, Pages 131-139

  Sena Esteves, Miguel ^a,b   Tebbets, Jessica C ^a   Steffens, Sabine ^a   Crombleholme, Timothy ^a   Flake, Alan W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

10A1; Amphotropic; LCMV; Lentivirus; Mokola; Pseudotype; Rabies; Vector; VSV G

Indexed keywords

BUTYRIC ACID; LENTIVIRUS VECTOR;

ARTICLE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LENTIVIRINAE; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; ULTRACENTRIFUGATION; ULTRAFILTRATION; VIRUS ENVELOPE;

CELL LINE; EBOLAVIRUS; GENETIC VECTORS; HIV-1; LENTIVIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PLASMIDS; TRANSDUCTION, GENETIC; TRANSFECTION; VESICULAR STOMATITIS-INDIANA VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL FUSION PROTEINS;

LENTIVIRUS;

EID: 7944234370     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2004.08.017     Document Type: Article

References (31)

1. V. Baekelandt, K. Eggermont, M. Michiels, B. Nuttin, and Z. Debyser Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain Gene Ther. 10 2003 1933 1940
2. W.R. Beyer, H. Miletic, W. Ostertag, and D. von Laer Recombinant expression of lymphocytic choriomeningitis virus strain WE glycoproteins: a single amino acid makes the difference J. Virol. 75 2001 1061 1064
3. W.R. Beyer, M. Westphal, W. Ostertag, and D. von Laer Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range J. Virol. 76 2002 1488 1495
4. N. Desmaris, A. Bosch, C. Salaun, C. Petit, M.C. Prevost, N. Tordo, P. Perrin, O. Schwartz, H. de Rocquigny, and J.M. Heard Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins Mol. Ther. 4 2001 149 156
5. G. Duisit, H. Conrath, S. Saleun, S. Folliot, N. Provost, F.L. Cosset, V. Sandrin, P. Moullier, and F. Rolling Five recombinant simian immunodeficiency virus pseudotypes lead to exclusive transduction of retinal pigmented epithelium in rat Mol. Ther. 6 2002 446 454
6. A. Follenzi, L.E. Ailles, S. Bakovic, M. Geuna, and L. Naldini Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences Nat. Genet. 25 2000 217 222
7. M. Gasmi, J. Glynn, M.J. Jin, D.J. Jolly, J.K. Yee, and S.T. Chen Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors J. Virol. 73 1999 1828 1834
8. M.T. Huang, and C.M. Gorman Intervening sequences increase efficiency of RNA 3′ processing and accumulation of cytoplasmic RNA Nucleic Acids Res. 18 1990 937 947
9. Y. Kang, C.S. Stein, J.A. Heth, P.L. Sinn, A.K. Penisten, P.D. Staber, K.L. Ratliff, H. Shen, C.K. Barker, I. Martins, C.M. Sharkey, D.A. Sanders, P.B. McCray Jr., and B.L. Davidson In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins J. Virol. 76 2002 9378 9388
10. B.A. Karolewski, D.J. Watson, M.K. Parente, and J.H. Wolfe Comparison of transfection conditions for a lentivirus vector produced in large volumes Hum. Gene Ther. 14 2003 1287 1296
11. G.P. Kobinger, D.J. Weiner, Q.C. Yu, and J.M. Wilson Filovirus- pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo Nat. Biotechnol. 19 2001 225 230
12. T.C. MacKenzie, G.P. Kobinger, N.A. Kootstra, A. Radu, M. Sena-Esteves, S. Bouchard, J.M. Wilson, I.M. Verma, and A.W. Flake Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes Mol. Ther. 6 2002 349 358
13. N.D. Mazarakis, M. Azzouz, J.B. Rohll, F.M. Ellard, F.J. Wilkes, A.L. Olsen, E.E. Carter, R.D. Barber, D.F. Baban, S.M. Kingsman, A.J. Kingsman, K. O'Malley, and K.A. Mitrophanous Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery Hum. Mol. Genet. 10 2001 2109 2121
14. H. Miyoshi, U. Blomer, M. Takahashi, F.H. Gage, and I.M. Verma Development of a self-inactivating lentivirus vector J. Virol. 72 1998 8150 8157
15. H. Mochizuki, J.P. Schwartz, K. Tanaka, R.O. Brady, and J. Reiser High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells J. Virol. 72 1998 8873 8883
16. K.W. Peng, L. Pham, H. Ye, R. Zufferey, D. Trono, F.L. Cosset, and S.J. Russell Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors Gene Ther. 8 2001 1456 1463
17. L. Pham, H. Ye, F.L. Cosset, S.J. Russell, and K.W. Peng Concentration of viral vectors by co-precipitation with calcium phosphate J. Gene Med. 3 2001 188 194
18. J. Reiser Production and concentration of pseudotyped HIV-1-based gene transfer vectors Gene Ther. 7 2000 910 913
19. T. Sakoda, N. Kasahara, Y. Hamamori, and L. Kedes A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes J. Mol. Cell Cardiol. 31 1999 2037 2047
20. M. Scherr, K. Battmer, M. Eder, S. Schule, H. Hohenberg, A. Ganser, M. Grez, and U. Blomer Efficient gene transfer into the CNS by lentiviral vectors purified by anion exchange chromatography Gene Ther. 9 2002 1708 1714
21. Y. Soneoka, P.M. Cannon, E.E. Ramsdale, J.C. Griffiths, G. Romano, S.M. Kingsman, and A.J. Kingsman A transient three-plasmid expression system for the production of high titer retroviral vectors Nucleic Acids Res. 23 1995 628 633
22. J. Stitz, C.J. Buchholz, M. Engelstadter, W. Uckert, U. Bloemer, I. Schmitt, and K. Cichutek Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1 Virology 273 2000 16 20
23. E. Verhoeyen, V. Dardalhon, O. Ducrey-Rundquist, D. Trono, N. Taylor, and F.L. Cosset IL-7 surface-engineered lentiviral vectors promote survival and efficient gene transfer in resting primary T lymphocytes Blood 101 2003 2167 2174
24. D.J. Watson, G.P. Kobinger, M.A. Passini, J.M. Wilson, and J.H. Wolfe Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins Mol. Ther. 5 2002 528 537
25. M.R. White, M. Masuko, L. Amet, G. Elliott, M. Braddock, A.J. Kingsman, and S.M. Kingsman Real-time analysis of the transcriptional regulation of HIV and hCMV promoters in single mammalian cells J. Cell Sci. 108 1995 441 455
26. L.F. Wong, M. Azzouz, L.E. Walmsley, Z. Askham, F.J. Wilkes, K.A. Mitrophanous, S.M. Kingsman, and N.D. Mazarakis Transduction patterns of pseudotyped lentiviral vectors in the nervous system Mol. Ther. 9 2004 101 111
27. K. Yamada, D.M. McCarty, V.J. Madden, and C.E. Walsh Lentivirus vector purification using anion exchange HPLC leads to improved gene transfer Biotechniques 34 2003 1074-1078, 1080
28. J.K. Yee, A. Miyanohara, P. LaPorte, K. Bouic, J.C. Burns, and T. Friedmann A general method for the generation of high-titer, pantropic retroviral vectors: highly efficient infection of primary hepatocytes Proc. Natl. Acad. Sci. U.S.A. 91 1994 9564 9568
29. R. Zufferey, J.E. Donello, D. Trono, and T.J. Hope Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors J. Virol. 73 1999 2886 2892
30. R. Zufferey, D. Nagy, R.J. Mandel, L. Naldini, and D. Trono Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo Nat. Biotechnol. 15 1997 871 875
31. R. Zufferey, and D. Trono Production of high-titer lentiviral vectors N.C. Dracopoli J.L. Haines B.R. Korf D.T. Moir C.C. Morton C.E. Seidman J.G. Seidman D.R. Smith Current Protocol in Human Genetics 2000 John Wiley & Sons New York 12.10.1 12.10.12